Evidence map›Paper›PMID 37108564›Full record

ArticleInternational journal of molecular sciences2023

Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.

Leonie Wittner, Lukas Wagener, Jakob J Wiese, Iris Stolzer, Susanne M Krug, Elisabeth Naschberger, Rene Jackstadt, Rudi Beyaert, Raja Atreya, Anja A Kühl and 10 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Seasonal PMParticle and fibre toxicology · 2025
    Article
  4. Article
  5. Article
  6. Solving the Puzzle: Molecular Research in Inflammatory Bowel Diseases.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Leonie WittnerDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.ORCID 0009-0008-7072-8001
Lukas WagenerDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Jakob J WieseDepartment of Gastroenterology, Rheumatology and Infectious Diseases, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.
Iris StolzerDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Susanne M KrugClinical Physiology/Nutritional Medicine, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.ORCID 0000-0002-1293-2484
Elisabeth NaschbergerDivision Molecular and Experimental Surgery, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.ORCID 0000-0003-1291-622X
Rene JackstadtCancer Progression and Metastasis Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Rudi BeyaertVIB-UGent Center for Inflammation Research, Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium.ORCID 0000-0002-5704-582X
Raja AtreyaDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Anja A KühlIBDome Consortium, 91054 Erlangen, Germany.ORCID 0000-0003-2293-5387
Gregor SturmBiocenter, Institute of Bioinformatics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-9584-7842
Miguel Gonzalez-AceraDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.ORCID 0009-0008-9445-5650
Jay V PatankarDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.ORCID 0000-0002-1884-7424
Christoph BeckerDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Britta SiegmundDepartment of Gastroenterology, Rheumatology and Infectious Diseases, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.ORCID 0000-0002-0055-958X
Zlatko TrajanoskiIBDome Consortium, 91054 Erlangen, Germany.
Beate WinnerDeutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Markus F NeurathDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Michael SchumannDepartment of Gastroenterology, Rheumatology and Infectious Diseases, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.
Claudia GüntherDepartment of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DECharité - Universitätsmedizin Berlin · DEInnsbruck Medical University · ATGerman Cancer Research Center · DEVIB-UGent Center for Inflammation Research · BE

Funding

Deutsche Forschungsgemeinschaft 375876048Deutsche Forschungsgemeinschaft 50553912Deutsche Forschungsgemeinschaft GU 1431/5-1
6 · The paper itself

Abstract

The paracaspase MALT1 is a crucial regulator of immune responses in various cellular contexts. Recently, there is increasing evidence suggesting that MALT1 might represent a novel key player in mucosal inflammation. However, the molecular mechanisms underlying this process and the targeted cell population remain unclear. In this study, we investigate the role of MALT1 proteolytic activity in the context of mucosal inflammation. We demonstrate a significant enrichment of MALT1 gene and protein expression in colonic epithelial cells of UC patients, as well as in the context of experimental colitis. Mechanistically we demonstrate that MALT1 protease function inhibits ferroptosis, a form of iron-dependent cell death, upstream of NF-κB signaling, which can promote inflammation and tissue damage in IBD. We further show that MALT1 activity contributes to STAT3 signaling, which is essential for the regeneration of the intestinal epithelium after injury. In summary, our data strongly suggests that the protease function of MALT1 plays a critical role in the regulation of immune and inflammatory responses, as well as mucosal healing. Understanding the mechanisms by which MALT1 protease function regulates these processes may offer novel therapeutic targets for the treatment of IBD and other inflammatory diseases.

Indexed as

Inflammatory Bowel DiseasesSignal TransductionEpithelial CellsHumansInflammationMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNF-kappa BProteolysisMALT1 protein, humanMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNF-kappa Bferroptosismucosal wound healingulcerative colitis

Identifiers

PMID37108564
PMCPMC10138456
OpenAlexW4366286979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.